IRVINE, Calif. (AP) — IRVINE, Calif. (AP) — Edwards Lifesciences Corp. (EW) on Thursday reported third-quarter earnings of $3.07 billion. On a per-share basis, the Irvine, California-based company ...
Edwards Lifesciences Corp. engages in the patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into three areas: Transcatheter Heart ...
The Edwards Lifesciences class action lawsuit further alleges that on July 24, 2024, Edwards Lifesciences disclosed second quarter 2024 TAVR results below expectations and lowered fiscal year 2024 ...